Lymphoedema Service Referral and Discharge Clinical Guideline V2.0 July 2018
|
|
- Nathan Bradford
- 5 years ago
- Views:
Transcription
1 Lymphoedema Service Referral and Discharge Clinical Guideline V2.0 July 2018
2 Summary Patient develops oedema Other causes investigated and treated (including DVT and Malignancy) Oedema remains Referral to Lymphoedema Referral triaged within 2 working days Declined Referrer contacted Urgent Patient offered an appointment > 2 weeks Accepted Cancer Patient offered an appointment > 6 weeks Non-cancer Patient offered an appointment > 8 weeks Assessment, Treatment and Review at the Lymphoedema Clinic Patient stable and able to self-manage Patient declines treatment or does not attend Patient discharged Page 2 of 12
3 1. Aim/Purpose of this Guideline 1.1 This policy clarifies the criteria for referral of patients to the Lymphoedema Clinic at the Royal Cornwall Hospital (RCH) and the discharge process that will be followed. 1.2 This guideline applies to anyone wishing to make a referral to the Lymphoedema service and to healthcare professionals in primary care who will provide continuing care for patients discharged from the service. 1.3 This version supersedes any previous versions of this document. 2. The Guidance Referral guidelines for the Lymphoedema Service 2.1 The RCH Lymphoedema Clinic is an outpatient clinic based solely at Treliske and is unable to provide domiciliary visits. 2.2 Patients will need to be able to travel to RCH Treliske to attend their outpatient appointment. Patients who are unable to travel to RCH should be managed by the Community Nursing team; the lymphoedema team can provide advice. Patients referred with lower limb or truncal oedema will need to be able to transfer onto the couch for assessment. If the patient needs hoisting or specific transfer aids for transfers please make this clear on the referral, failure to do so may mean that the patient cannot be assessed at their planned appointment. 2.3 The lymphoedema team can provide telephone advice for inpatients within the Royal Cornwall Hospital Trust, however management will need to be undertaken by the ward team. Inpatients may be referred for outpatient appointments using the lymphoedema clinic referral form if the condition is related to the patients existing condition. Referrals for unrelated lymphoedema need to be made via the GP. 2.4 The RCH Lymphoedema Clinic will assess and treat patients with oedema that has been present for more than 3 months. This includes: Primary Lymphoedema Secondary Lymphoedema related to cancer and other causes, Lipoedema Obesity related oedema Chronic oedema 2.5 Patients with cancer related oedema will be accepted prior to the 3 month threshold, however acute causes must be ruled out prior to referral. In addition patients with cancer and lower limb oedema must have been screened for DVT and this must have been ruled out prior to referral; this must be stated clearly on the referral. 2.6 Patients with oedema associated with known or suspected arterial insufficiency should be referred to the vascular service for further advice regarding lymphoedema management prior to referral to lymphoedema. Page 3 of 12
4 2.7 Patients with a BMI over 40, with bilateral lower limb oedema, should be referred to a weight management programme prior to referral to lymphoedema. Clinical evidence provides a strong link between obesity and chronic oedema and unless the primary cause of the obesity is addressed treatment will be ineffective. 2.8 Only written referrals will be accepted. Referrals should be made using the Referral Management Service or sent to the Lymphoedema Team, Therapy Department, PAW, Royal Cornwall Hospital, Truro TR1 3LJ or rchtr.lymphoedema@nhs.net Referrals will not be accepted if the information is incomplete, this may delay the patient being offered an appointment. If the referral is urgent please state the reason for urgency clearly on the referral. (the referral form is available Referrals will be accepted from all Healthcare Professionals: Referrals are accepted directly from the GP or Practice Nurse. Referrals will be accepted from the patient s medical Consultant when the lymphoedema directly relates to the condition they are under their care for, referrals for new and unrelated lymphoedema must be made via the GP. For referrals from other Healthcare Professionals, once the referral is accepted by the lymphoedema service, the GP will be contacted by letter to confirm that they agree with and support the referral Referrals will be accepted for children (of any age) and adults with lymphoedema. Referrals for children will be discussed on a case by case basis with the multi-disciplinary team and may be referred on for further assessment to a regional centre of excellence Referrals will be accepted for patients from Cornwall and the Isles of Scilly. Patients who meet the criteria of the following neighbouring services, Cornwall Hospice Care, St Luke s Hospice and North Devon Hospital will be given the choice of where they wish to attend Referrals will be triaged within 2 working days of receipt and urgent referrals contacted to agree an appointment. We aim to see urgent or palliative patients within 2 weeks and all other patients in 8 weeks. 3. Discharge guidelines for the Lymphoedema Service 3.1 The lymphoedema service offers a specialist outpatient service for persons with lymphoedema. It is the aim of the service to enable patients to selfmanage this long term condition. A well-controlled lymphoedema or chronic oedema, will be maintained by the patient with the support of primary care. Page 4 of 12
5 3.2 These guidelines outline which patients will be discharged and the procedures to be followed when discharging patients from the Lymphoedema service at the Royal Cornwall Hospital. This will ensure that within the confines of available resources, all patients are treated in an equitable manner and all members of the team, patients, family and relevant others understand the procedure to be followed. 3.3 Appropriate discharge planning will be arranged for all patients who meet the requirements for a safe discharge from the Lymphoedema Service. The requirements for safe discharge are: The patient has reached the agreed outcomes for intervention. The patient is stable, is able to self-manage and does not require further treatment or has been stable and maintained for 12 months on their current treatment regime. The patient/carer must be able to understand their condition and the necessary action if any abnormalities should occur. The patient will be wearing garments available on prescription, or if this is not possible supplied by the appliances department on receipt of an annual request from the patients GP. Patients with lympho-venous or gravitational oedema can be managed within primary care initially. However, if referred to the Lymphoedema Service the patient will be assessed, treated and reviewed and then discharged for maintenance by primary care. In addition the followings patients will also be discharged: Patients who are deemed non-adherent and do not accept prescribed treatment following consultation. Patients with no evidence of lymphoedema or chronic oedema at assessment. Patients who it is not safe to offer treatment to, due to their comorbidities. Patients with obesity related lymphoedema who have not met their agreed weight-loss goal. 3.4 Patients who DNA will be discharged in line with the Patient Access Policy (2013). Patients who do not attend their initial assessment will be discharged. Patients under the age of 18 will be discharged in line with the RCH Did Not Attend, Cancellation and refusal of Appointments Policy for Children and Young People up to the Age of 18 Years Policy. Patients who do not attend a review appointment will be contacted and requested to rebook their appointment within 4 weeks, if the patient does not contact the clinic then they will be discharged Patients who cancel 2 or more appointments within an active course of treatment. The patient and their GP will be informed by written correspondence. Page 5 of 12
6 3.5 The assessing therapist will make the final decision to discharge. 3.6 Discharge planning should be discussed with the patient as soon as they become stable and will form part of the patient s education, enabling selfmanagement. 3.7 When the discharge process has been discussed with the patient, their views are noted and it may be necessary to liaise with relevant others. 3.8 The following discharge advice will be discussed with the patient and / or carer prior to discharge and written information will be provided. Patients will be made aware of potential complications of their condition, and will be advised what to do and who to contact if a problem should occur. Patients will be provided with the relevant patient information they require to manage their condition. Any resource required by the patient should be issued or ordered and explained how to obtain subsequent orders 3.9 The discharge will be documented in the patient s notes and a letter will be sent to GP, patient and relevant others with details of the necessary follow up care. 4. Monitoring compliance and effectiveness Referral Guideline: Element to be Appropriateness of referrals received. monitored Number of incomplete referrals. Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Clinical Leads Lymphoedema Team Compare each referral with this guidance Each referral received will be monitored Referrer to be contacted with the reasons the referral has been declined or is incomplete. Clinical Leads in Lymphoedema to address any persistent nonconformance (if identified) with specific referrers Required changes to practice will be identified and actioned within 6 months of implementation. A lead member of the team will be identified to take these changes forward where appropriate. Lessons will be shared with all the relevant stakeholders. Page 6 of 12
7 Discharge Guideline: Element to be monitored Patients meeting the discharge criteria are discharged appropriately Number of re-referrals to the service Lead Tool Frequency Reporting arrangements Acting on recommendations and Lead(s) Change in practice and lessons to be shared Clinical Leads Lymphoedema Team Peer review of case load and discharges Review of re-referrals and monitor reason for re-referral Annual peer review Ongoing monitoring of re-referrals Action plan following above to be reported back to Outpatient Team Lead Clinical Leads in Lymphoedema to establish any variance in implementing the policy and work towards ensuring there is a consistent and equitable approach Required changes to practice will be identified and actioned within 6 months of implementation. A lead member of the team will be identified to take these changes forward where appropriate. Lessons will be shared with all the relevant stakeholders. 5. Equality and Diversity a. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the 'Equality, Diversity & Human Rights Policy' or the Equality and Diversity website. b. Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendix 2. Page 7 of 12
8 Appendix 1. Governance Information Document Title Lymphoedema Service Referral and Discharge Clinical Guideline V2.0 Date Issued/Approved: 17 th July 2018 Date Valid From: 17 th July 2018 Date Valid To: 17 th July 2021 Directorate / Department responsible (author/owner): Emma Underwood, Lymphoedema Specialist (OT) CSCS Contact details: Brief summary of contents Guidance for those wishing to refer to the Lymphoedema Clinic RCHT on referral procedure and criteria and the discharge process Suggested Keywords: Target Audience Executive Director responsible for Policy: Date revised: 20/06/2017 This document replaces (exact title of previous version): Approval route (names of committees)/consultation: Divisional Manager confirming approval processes Lymphoedema, Referral and Discharge RCHT CPFT KCCG Lymphoedema Referral and Discharge Policy v1.0 Therapies Clinical Governance Forum Dec 2017 Therapies Clinical and Quality Assurance Group Jan 2018 CSCS Governance DMB approval July 2018 Karen Jarvill Associate Director CSCS Name and Post Title of additional signatories Name and Signature of Divisional/Directorate Governance Lead confirming approval by specialty and divisional management meetings Signature of Executive Director giving approval Not Required {Original Copy Signed} Name: Kevin Wright CSCS Clinical Governance Lead {Original Copy Signed} Page 8 of 12
9 Publication Location (refer to Policy on Policies Approvals and Ratification): Document Library Folder/Sub Folder Internet & Intranet Intranet Only Clinical/Occupational Therapy Links to key external standards Related Documents: Training Need Identified? None No Version Control Table Date Version No Summary of Changes Changes Made by (Name and Job Title) May 2014 V1.0 Initial Issue Emma Underwood Lymphoedema Specialist (OT) 20/6/17 V2.0 Policy reviewed, contact details updated, appendices removed as available on the website as stand-alone leaflets and link to new referral form added. Emma Underwood Lymphoedema Specialist (OT) All or part of this document can be released under the Freedom of Information Act 2000 This document is to be retained for 10 years from the date of expiry. This document is only valid on the day of printing Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy on Document Production. It should not be altered in any way without the express permission of the author or their Line Manager. Page 9 of 12
10 Appendix 2. Initial Equality Impact Assessment Form This assessment will need to be completed in stages to allow for adequate consultation with the relevant groups. Name of Name of the strategy / policy /proposal / service function to be assessed Directorate and service area: Clinical Support and Cancer Services - Therapy Is this a new or existing Policy? Existing Name of individual completing assessment: Telephone: Emma Underwood 1. Policy Aim* To provide information on the referral and discharge process Who is the strategy / policy / proposal / service function aimed at? 2. Policy Objectives* 3. Policy intended Outcomes* To raise awareness of the referral process To ensure a safe and equitable discharge process 4. *How will you measure the outcome? 5. Who is intended to benefit from the policy? 6a Who did you consult with b). Please identify the groups who have been consulted about this procedure. Number of incorrect or incomplete referrals received Number of re-referrals due to poor access to ongoing care in the community Patients Workforce Patients Local groups External organisations Other Therapies Clinical Governance Forum Dec 2017 Therapies Clinical & Quality Assurance Group Approval June 2018 CSCS Governance DMB approval July 2018 Page 10 of 12
11 What was the outcome of the consultation? Request for assurance over the exclusion criteria and rationale sought and for this to be clarified in the wording of the document. 7. The Impact Please complete the following table. If you are unsure/don t know if there is a negative impact you need to repeat the consultation step. Are there concerns that the policy could have differential impact on: Equality Strands: Yes No Unsure Rationale for Assessment / Existing Evidence Age Sex (male, female, trans-gender / gender reassignment) Race / Ethnic communities /groups Disability - Learning disability, physical impairment, sensory impairment, mental health conditions and some long term health conditions. Religion / other beliefs Marriage and Civil partnership Pregnancy and maternity Sexual Orientation, Bisexual, Gay, heterosexual, Lesbian You will need to continue to a full Equality Impact Assessment if the following have been highlighted: You have ticked Yes in any column above and No consultation or evidence of there being consultation- this excludes any policies which have been identified as not requiring consultation. or Major this relates to service redesign or development Page 11 of 12
12 8. Please indicate if a full equality analysis is recommended. Yes No 9. If you are not recommending a Full Impact assessment please explain why. Signature of policy developer / lead manager / director Emma Underwood Date of completion and submission 1/2/18 Names and signatures of members carrying out the Screening Assessment 1. Emma Underwood 2. Human Rights, Equality & Inclusion Lead Keep one copy and send a copy to the Human Rights, Equality and Inclusion Lead c/o Royal Cornwall Hospitals NHS Trust, Human Resources Department, Knowledge Spa, Truro, Cornwall, TR1 3HD This EIA will not be uploaded to the Trust website without the signature of the Human Rights, Equality & Inclusion Lead. A summary of the results will be published on the Trust s web site. Signed Emma Underwood Date 01/02/18 Page 12 of 12
Loading Dose Worksheet for Oral Amiodarone
This applies to adult patients only Key: General Notes ED/MAU/SRU/Acute GP/Amb-Care GP/SWASFT In-patient wards Start Prescribe as per loading dose worksheet below End 1. Aim/Purpose of this Guideline 1.1.
More informationClinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline
Clinical Guideline for Post-Operative Nausea and Vomiting 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide anaesthetists with an algorithm to work with when dealing with
More informationCLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR REFERRAL TO PAIN SERVICE 1. Aim/Purpose of this Guideline To provide guidance for appropriate referral to the acute pain service for in-patient review. 2. The Guidance PAIN SERVICES
More informationCLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start
CLINICAL GUIDELINE FOR CLINICAL IMAGING REFERRAL PROTOCOL FOR NURSE SPECIALISTS IN HEART FUNCTION WITHIN RCHT Summary. Start The non-medical practitioner has received sufficient training to make clinical
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE MANAGEMENT OF SEPSIS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline 1.1. This guideline aims to improve outcomes for patients presenting with sepsis or developing sepsis
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationA list of authorised referrers will be retained by the Colposcopy team and the Clinical Imaging Department.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Colposcopist within Colposcopy Dept. Royal Cornwall Hospital 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse Colposcopist
More informationCLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE
CLINICAL IMAGING REFERRAL PROTOCOL FOR REGISTERED NURSE PRACTITIONERS IN THE EMERGENCY DEPARTMENT, URGENT CARE CENTRE AND AMBULATORY CARE CLINICAL GUIDELINE V4. Summary. Start The non-medical practitioner
More informationCLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS)
CLINICAL GUIDELINE FOR THE ASSESSMENT AND DOCUMENTATION OF PAIN (ADULTS) 1. Aim/Purpose of this Guideline 1.1. Pain is whatever the experiencing person says it is, existing whenever the experiencing person
More informationPolicy on Governance Arrangements Relating to Medicines V2.0
V2.0 August 2015 Summary. The policy outlines the governance arrangements for medicines within the Trust, specifically; 1. The committee structure in the Trust and the county for medicine related matters
More informationDiagnostic Testing Procedures in Urodynamics V3.0
V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.
More informationPolicy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0
Policy for the authorising of blood components by the Haematology Clinical Nurse Specialist V1.0 January 2016 Summary. This policy applies only to selected staff within the Haematology Department at the
More informationCLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0
CLINICAL GUIDELINE FOR THE ADMISSION OF PATIENTS TO PAEDIATRIC HIGH DEPENDANCY UNIT V4.0 Page 1 of 13 Abbreviation (P/A)HDU (P/A)ICU GCS IPPV CPAP BiPAP DKA Reg Meaning (Paediatric/Adult) High Dependency
More information1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Endoscopist (Lower GI) within the Royal Cornwall Hospitals Trust 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse
More informationCLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS
CLINICAL GUIDELINE FOR USE OF BED AND CHAIR SENSOR ALARM MATS FOR PREVENTING FALLS IN ADULT PATIENTS 1. Aim/Purpose of this Guideline This guideline is to support the use of bed and chair sensor alarm
More informationClinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline
Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist. 1. Aim/Purpose of this Guideline 1.1 This protocol applies to upper & lower GI Non medical Endoscopist
More informationCLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE USE OF INTRAVENOUS SLIDING SCALE REGIMEN FOR ADULTS 1. Aim/Purpose of this Guideline This guideline is for the management of for the management of Adult patients with Mellitus
More informationPARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
PARACETAMOL PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationOXYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0
OYGEN THERAPY AND SATURATION MONITORING OF THE NEONATE - CLINICAL GUIDELINE V3.0 1. Aim/Purpose of this Guideline 1.1 To provide guidance on the assessment and management of infants requiring oxygen therapy
More informationCLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR IPRATROPIUM BROMIDE NEBULISER INHALER PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical
More informationCLINICAL GUIDELINE FOR: Management of low-risk upper GI haemorrhage. Page 1 of 10. Management of low-risk upper GI haemorrhage
CLINICAL GUIDELINE FOR: Page 1 of 10 Summary AGE
More informationSchool Vision Screening Policy V2.0
School Vision Screening Policy V2.0 05 April 2016 Summary. Vision screening test in school PASS Visual acuity LogMAR 0.2 both eyes Kays 0.1 both eyes Outcome letter sent home Test result information put
More informationClinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.
Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and
More informationCLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy
More informationIBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline
IBUPROFEN PATIENT GROUP DIRECTION CHILD HEALTH 1. Aim/Purpose of this Guideline 1.1. This Patient Group Direction (PGD) applies to all nursing and clinical staff in the Child Health Department and its
More informationSafe Bathing Policy V1.3
V1.3 April 2018 Summary Safe hot water temperatures The hot water distribution temperatures, which are required for the control and prevention of Legionella, can lead to discharge temperatures in excess
More informationESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline
ESCALATION PLAN PAEDIATRICS AND NEONATAL UNIT 1. Aim/Purpose of this Guideline 1.1. This guidance is designed to aid staff to monitor capacity and staffing in Child Health. 2. The Guidance 2.1. The majority
More information2.1. Applicable areas: Royal Cornwall Hospitals Trust; Neonatal Unit and Delivery Suite
ADVANCED NEONATAL NURSE PRACTITIONERS (ANNPs) BLOOD COMPONENT AND BLOOD PRODUCT REQUESTING PROTOCOL NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 The purpose of this protocol is to guide
More informationNewborn Hearing Screening Programme Policy
Newborn Hearing Screening Programme Policy V3.0 December 2015 Page 1 of 16 Summary - Screening Pathway for Newborn Hearing Screening Newborn hearing screening Check eligibility Eligible for screening Not
More informationThis guideline is for nursing staff within the Pain Services assisting with the administration of botulinum toxin.
CLINICAL GUIDELINE FOR THE SAFE ADMINISTRATION OF BOTULINUM NEURO TOIN FOR INJECTION within the PAIN SERVICE. Botox and eomin (trade names) 1. Aim/Purpose of this Guideline This guideline is for nursing
More informationDiagnostic Testing Procedures in Neurophysiology V1.0
V1.0 10 September 2012 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the
More informationTissue Viability Referral Pathway. April 2017
Tissue Viability Referral Pathway V4 April 2017 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...
More informationThe initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0
The initial care and management of patients admitted to RCHT with a Ventricular Assist Device (VAD). V2.0 October 2016 Summary. Start See section 6.2 of this document for important information regarding
More information2.1. It is essential that promoting and safeguarding the welfare of children and young people is integral to all NHS Trust policies and procedures.
Was Not Brought, Cancellation and Refusal of Appointments Policy for Children and Young People up to the Age of 18 Years (up to the age of 25 years for people with a Learning Disability) 1. Aim/Purpose
More informationWARD CLOSURE POLICY V
WARD CLOSURE POLICY V3.0 29.07.15 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 4 5.1.
More informationPRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0
PRESCRIBING, DISPENSING AND ADMINISTRATION OF CHEMOTHERAPY TO CHILDREN AND YOUNG PEOPLE - CLINICAL GUIDELINE V4.0 Clinical Guideline Template Page 1 of 14 1. Aim/Purpose of this Guideline 1.1. This guideline
More informationDiagnostic Testing Procedures for Ophthalmic Science
V4.0 01/08/17 Table of Contents 1. Introduction... 3 2. Purpose of this Policy... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the Managers... 3 5.3.
More informationProcedure for the Application of a Cast and its subsequent care V1.3
Procedure for the Application of a Cast and its subsequent care V1.3 May 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary...
More informationSafeguarding Children Supervision Policy V4.0. November 2016
Safeguarding Children Supervision Policy V4.0 November 2016 Page 1 of 20 Summary Part 1 Part 2 Safeguarding supervision for Nursing and Midwifery staff, Paediatricians, Medical Staff and other Allied Health
More informationCLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND
CLINICAL GUIDELINE FOR THE EMERGENCY DEFILL OF AN ADJUSTABLE GASTRIC BAND 1. Aim/Purpose of this Guideline The aim of this guideline to enable the effective care of patients needing emergency defill of
More informationPatient Experience Strategy
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationMANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
MANAGEMENT OF HEREDITARY SPHEROCYTOSIS IN THE NEONATAL PERIOD CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1 This guideline aimed at all clinical staff responsible for the management of infants
More informationCLINICAL GUIDELINE FOR TRANSFERS AND DISCHARGES IN THE LAST FEW WEEKS OF LIFE 1. Aim/Purpose of this Guideline
POLICY UNDER REVIEW Please note that this policy is under review. It does, however, remain current Trust policy subject to any recent legislative changes, national policy instruction (NHS or Department
More informationCLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary.
CLINICAL GUIDELINE FOR MAXIMUM SURGICAL BLOOD ORDER SCHEDULE (MSBOS) Summary. Start Elective procedure identified, blood requirement listed in guideline Patient attends PAC and has a group and screen (G&S)
More informationCEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline
CEREBRAL FUNCTION MONITORING (aeeg). NEONATAL CLINICAL GUIDELINE 1. Aim/Purpose of this Guideline 1.1. To provide guidance on the operation and interpretation of Cerebral Function Monitoring (CFM) in neonates.
More informationHealth and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0
Health and Safety Policy and Guidance for Staff Working During Night Time Hours V2.0 January 2016 Summary Purpose of the document: The purpose of this policy is to provide an outline of the requirements
More informationOccupational Health Surveillance Policy V2.1
Occupational Health Surveillance Policy V2.1 May 2016 Table of Contents 1. Introduction... 2 2. Purpose of this Policy... 2 3. Scope... 2 4. Definitions/Glossary... 3 5. Ownership and Responsibilities...
More informationSafe Staffing Levels for. Midwifery, Nursing and Support Staff. For Maternity Service - Approved. Document V1.5. June 2017
Safe Staffing Levels for Midwifery, Nursing and Support Staff For Maternity Service - Approved V1.5 June 2017 Jan Walters Head of Midwifery Women, Children and Sexual Health Division CONTENTS Section Page
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationEarly detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0
Early detection, management and control of carbapenemase-producing Enterobacteriaceae Policy V3.0 01.05.2018 Summary - Patient admission flow chart for the infection prevention and control of carbapenemase-producing
More informationIt is essential that patients are aware of, and in agreement with, their referral to palliative care.
Title: Directorate: Responsible for review: Ratified by: CHRONIC HEART FAILURE REFERRAL TO PALLIATIVE CARE SERVCES Palliative Care Consultant in Palliative Care Care and Clinical Policies Group Ref No:
More informationPHARMACEUTICAL REPRESENTATIVE POLICY NOVEMBER This policy supersedes all previous policies for Medical Representatives
PHARMACEUTICAL REPRESENTATIVE POLICY VEMBER 2017 This policy supersedes all previous policies for Medical Representatives Policy title Pharmaceutical Representative Policy Policy PHA39 reference Policy
More informationProvision of Wigs Policy
Post holder responsible for Procedural Document Author and post holder of Policy Division/Department responsible for Procedural Document Contact details Lead Cancer Nurse Tina Grose, Lead Cancer Nurse
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients
The Newcastle upon Tyne Hospitals NHS Foundation Trust Medicines Reconciliation Policy and Procedure for Adult and Paediatric Patients Version.: 2.0 Effective From: 15 March 2018 Expiry Date: 15 March
More informationSevere Weather Plan V5.5 March 2018
V5.5 March 2018 Table of Contents 1. Introduction 3 2. Purpose of this Plan. 3 3. Scope. 3 4. Ownership and Responsibilities. 3 5. Escalation Levels and Actions 5 6. Staffing Contingency and Guidance.
More informationPerson/persons conducting this assessment with Contact Details Marilyn Rees Lead VTE Nurse ext 48729
Appendix 2 - Equality Impact Assessment - Thromboprophylaxis Policy for Adult In-Patients Section A: Assessment Name of Policy Thromboprophylaxis Policy for Adult In-Patients Person/persons conducting
More informationThe Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy
The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patient Choice Directive Policy & Guidance
The Newcastle upon Tyne Hospitals NHS Foundation Trust Patient Choice Directive Policy & Guidance Version No.: 2.1 Effective From: 26 August 2014 Expiry Date: 26 August 2016 Date Ratified: 17 June 2014
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Procedure for Monitoring of Delayed Transfers of Care
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for Monitoring of Delayed Transfers of Care Version No.: 2.2 Effective From: 17 March 2015 Expiry Date: 17 March 2018 Date Ratified: 25
More informationVersion Number Date Issued Review Date V1: 28/02/ /08/2014
Corporate CCG CO01 Access and Choice Policy Version Number Date Issued Review Date V1: 28/02/2013 31/08/2014 Prepared By: Consultation Process: Governance Lead, NHS South of Tyne and Wear Information Governance
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Use of Patients Own Drugs (PODs)
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Use of Patients Own Drugs (PODs) Version.: 2.2 Effective From: 20 January 2016 Expiry Date: 20 January 2019 Date Ratified: 13 January 2016 Ratified
More informationRCHT Non-Ionising Radiation Safety Policy
V3.0 June 2015 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 4 4. Definitions / Glossary... 5 5. Ownership and Responsibilities... 5 6. Standards and Practice...
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Patients Wills Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Version No: 5.0 Effective From: 7 September 2017 Expiry Date: 31 August 2018 Date Ratified: 30 August 2017 Ratified By: Executive Team 1 Introduction
More informationNon Attendance (Did Not Attend-DNA ) Policy. Executive Director of Nursing and Chief Operating Officer
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Non Attendance (Did Not Attend-DNA) NTW(C)06 Executive Director of Nursing and Chief Operating Officer Ann Marshall
More informationDocument Author: Tissue Viability Nurse Date 15/02/2017
Guideline Title: Ref No: 1820 Version: 2 Document Author: Tissue Viability Nurse Date 15/02/2017 Ratified by: Care and Clinical Policies Group Date: 15/02/2017 Review date: 10 March 2019 Links to policies:
More informationReferral to Treatment (RTT) Access Policy
General Referral to Treatment (RTT) Access Policy This is a controlled document and whilst this document may be printed, the electronic version posted on the intranet/shared drive is the controlled copy.
More informationCLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage
CLINICAL GUIDELINE FOR Management of NON-VARICEAL Upper GI haemorrhage Suspected Non Variceal upper GI haemorrhage If any features suggest liver disease consult the variceal haemorrhage guideline http://www.rcht.nhs.uk/documentslibrary/royalcornw
More informationCLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES
CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES RATIONALE Access to Community Podiatry services and treatment intervals for Diabetic patients, will generally be determined by the
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Named Key Worker for Cancer Patients Policy Version No.: 4 Effective 07 December 2017 From: Expiry Date: 07 December 2020 Date Ratified: 17 October
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Strong Potassium Solutions Safe Handling and Storage
The Newcastle upon Tyne Hospitals NHS Foundation Trust Strong Potassium Solutions Safe Handling and Storage Version : 5.3 Effective From: 19 January 2016 Expiry Date: 19 January 2019 Date Ratified: 14
More informationConsultant to Consultant Referral Policy
Consultant to Consultant Referral Policy Version Author Date Comments Approved by No V1.0 Mel Sims 19 January 2017 To be APPROVED Governing Body Reader information Reference Document purpose COM002 This
More informationExecutive Director of Nursing and Chief Operating Officer
Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15
More informationThis procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services
Patient Access Policy November 2013 This procedural document supersedes the previous procedural documents for Policy for the Management of Patients/Clients Access to Services Version: 1.0 Policy reference
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Code of Practice for Wound Care Company Representatives and Staff with whom they interact
The Newcastle upon Tyne Hospitals NHS Foundation Trust Code of Practice for Wound Care Company Representatives and Staff with whom they interact Version No.: 1.1 Effective From: 8 th January 2015 Expiry
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationDrainage of Abdominal Ascites
Drainage of Abdominal Ascites Standard Operating Procedure (SOP) Prepared by: Cancer & Vascular Access Advanced Nurse Practitioner Presented to: Date: Care and Clinical Policies Group 18 January 2017 Cancer
More informationDefining the Boundaries between NHS and Private Healthcare. MECCG Policy Reference: MECCG142
Defining the Boundaries between NHS and Private Healthcare MECCG Policy Reference: MECCG142 Target Audience Brief Description (max 50 words) Action Required Equality Impact Assessment Providers of private
More informationAnimals and Pets in Healthcare Facilities Policy
Animals and Pets in Healthcare Facilities Policy Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Judy Potter,
More informationNORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY
PLEASE NOTE POLICY IS UNDER REVIEW NORTH EAST ESSEX CLINICAL COMMISSIONING GROUP CONSULTANT TO CONSULTANT REFERRAL POLICY Target Audience Brief Description (max 50 words) Action Required Providers, Commissioners
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Strategy for Non-Medical Prescribing
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Strategy for Non-Medical Prescribing Version No: 2.2 Effective From: 19 October 2016 Expiry Date: 19 October 2019 Date Ratified: 12 October 2016 Ratified
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Water Safety Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Water Safety Policy Version No.: 2.0 Effective From: 09 February 2018 Expiry Date: 09 February 2021 Date Ratified: 09 November 2017 Ratified By: Infection
More informationSTANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES
STANDARD OPERATING PROCEDURE ADMINISTRATION OF HEPARIN FLUSHES VIA CENTRAL INTRAVENOUS ACCESS DEVICES First Issued Issue Version One Purpose of Issue/ Description of Change To promote the safe administration
More informationHOME TREATMENT SERVICE OPERATIONAL PROTOCOL
HOME TREATMENT SERVICE OPERATIONAL PROTOCOL Document Type Unique Identifier To be set by Web and Systems Development Team Document Purpose This protocol sets out how Home Treatment is provided by Worcestershire
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationPositive and Safe Management of Post incident Support and Debrief. Ron Weddle Deputy Director, Positive and Safe Care
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Positive and Safe Management of Post incident Support and Debrief NTW(C)13 Ron Weddle Deputy Director, Positive
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationDid Not Attend (DNA) and Cancellation Policy and Operational Guidelines
Did Not Attend (DNA) and Cancellation Policy and Operational Guidelines Document Number Version Ratified By & Date Name of Approving Body(s) & Date(s) FPE-004 V1 Safety and Effectiveness Sub-Committee
More informationWig and Hair Replacement Policy
Leeds CCGs Wigs and Hair Replacement Policy 2016-19 Wig and Hair Replacement Policy Version: 2016-19 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 vember 2016 NHS Leeds rth CCG Governance
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust
The Newcastle upon Tyne Hospitals NHS Foundation Trust Procedure for registration and supply of prophylaxis to the immediate household contacts of patients admitted with meningococcal disease Version.:
More informationPolicy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013
Policy for Failure to Bring/Attend Children s Health Appointments Whittington Health 2012/2013 Subject: Policy Number: 1 Ratified by: Policy for Failure to Bring/Attend and Cancellation of Children s Health
More informationHepatitis B Immunisation procedure SOP
Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical
More informationEquality Information Introduction. 2. Our patients and our workforce
Equality Information 2018 1. Introduction NHS Kernow has legal duties to meet under the Equality Act 2010 and the Public Sector Equality Duty (PSED). This paper summarises our legal duties to our employees
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationManual Handling Policy
Manual Handling Policy Document Information This is a controlled document. It should not be altered in any way without the express permission of the author or their representative. On receipt of a new
More informationSERVICE SPECIFICATION
SERVICE SPECIFICATION Service Rotherham Hospice Lead Gail Palmer Provider Lead Paula Hill / Mike Wilkerson Period 21 st July 2010 20 th July 2013 1. Purpose This specification describes the services which
More informationHand Hygiene Policy V2.1
V2.1 October 2017 Summary. Effective hand hygiene is shown to significantly reduce the carriage of potential pathogens and decrease the risk and occurrence of healthcare associated infections. Each individual
More informationPolicy for Patient Access
Policy for Patient Access DOCUMENT CONTROL Revision Date Old Version 10/12/2014 1.0 01/07/2016 1.1 30/04/17 1.2 Amendment General Management Review General Management Review General Management Review Authored
More informationSpecialised Services Commissioning Policy: CP160 Specialised Paediatric Neurological Rehabilitation
Specialised Services Commissioning Policy: CP160 Specialised Paediatric Neurological Rehabilitation April 2018 Version 4.0 Document information Document purpose Document name Author Policy Specialised
More informationDocument Title: GCP Training for Research Staff. Document Number: SOP 005
Document Title: GCP Training for Research Staff Document Number: SOP 005 Version: 2 Ratified by: Version 2, 04/10/2017 Page 1 of 13 Committee Date ratified: 26/10/2017 Name of originator/author: Directorate:
More informationOutbreak Control Policy
Post holder responsible for Procedural Document Author of Guideline Division/ Department responsible for Procedural Document Contact details Date of original policy / strategy/ standard operating procedure/
More information